Fundraising Fox
GLX Analytix
15 employees on LinkedIn · 2 known investors
Find your way into GLX Analytix
Sign up to see every warm intro you have to GLX Analytix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GLX Analytix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
GLX Analytix develops a blood test platform that measures glycocalyx fragments and uses AI/ML to create disease-specific biomarker signatures for diagnosing and monitoring brain diseases including neuropsychiatric, neurodegenerative, and autoimmune conditions. The company targets clinicians and healthcare providers seeking early detection and precision medicine insights for conditions like Parkinson's, multiple sclerosis, schizophrenia, and stroke.
Founders & leadership
Investors · 2
How we know: DigitalDx Ventures's portfolio page · funding news · press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
Frequently asked questions
- What does GLX Analytix do?
- GLX Analytix develops a blood test platform that measures glycocalyx fragments and uses AI/ML to create disease-specific biomarker signatures for diagnosing and monitoring brain diseases including neuropsychiatric, neurodegenerative, and autoimmune conditions. The company targets clinicians and healthcare providers seeking early detection and precision medicine insights for conditions like Parkinson's, multiple sclerosis, schizophrenia, and stroke.
- Who founded GLX Analytix?
- GLX Analytix was founded by Brian.
- Who are GLX Analytix's investors?
- GLX Analytix's investors include DigitalDx Ventures, Vaekstfonden.